These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 34878363

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples.
    Tolan NV, Vidal-Folch N, Algeciras-Schimnich A, Singh RJ, Grebe SK.
    Clin Chim Acta; 2013 Sep 23; 424():216-21. PubMed ID: 23778024
    [Abstract] [Full Text] [Related]

  • 3. The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis.
    Liu XM, Liu XH, Mao MJ, Liu YJ, Wang JY, Dai SQ.
    J Clin Lab Anal; 2021 Sep 23; 35(9):e23895. PubMed ID: 34233042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum.
    Berger R, Richichi R.
    Pediatr Crit Care Med; 2009 Mar 23; 10(2):260-3. PubMed ID: 19188872
    [Abstract] [Full Text] [Related]

  • 8. Invisible hemolysis in serum samples interferes in NSE measurement.
    Mastroianni A, Panella R, Morelli D.
    Tumori; 2020 Feb 23; 106(1):79-81. PubMed ID: 31394980
    [Abstract] [Full Text] [Related]

  • 9. [Importance of hemolysis on neuron-specific enolase measurement].
    Planche V, Brochet C, Bakkouch A, Bernard M.
    Ann Biol Clin (Paris); 2010 Feb 23; 68(2):239-42. PubMed ID: 20348052
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuron-specific enolase levels immediately following cardiovascular surgery is modulated by hemolysis due to cardiopulmonary bypass, making it unsuitable as a brain damage biomarker.
    Motoyoshi N, Tsutsui M, Soman K, Shirasaka T, Narita T, Kunioka S, Naya K, Yamazaki D, Narita M, Kamiya H.
    J Artif Organs; 2024 Jun 23; 27(2):100-107. PubMed ID: 37120686
    [Abstract] [Full Text] [Related]

  • 13. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury?
    Schmitt B, Bauersfeld U, Schmid ER, Tuchschmid P, Molinari L, Fanconi S, Bandtlow C.
    Brain Dev; 1998 Oct 23; 20(7):536-9. PubMed ID: 9840675
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors.
    Martens P.
    Acad Emerg Med; 1996 Feb 23; 3(2):126-31. PubMed ID: 8808372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.